165 related articles for article (PubMed ID: 9288171)
1. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
Yu Q; Greig NH; Holloway HW; Brossi A
J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
7. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine.
Yu QS; Atack JR; Rapoport SI; Brossi A
J Med Chem; 1988 Dec; 31(12):2297-300. PubMed ID: 3193422
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain.
Gavuzzo E; Pomponi M
J Biochem Mol Toxicol; 2002; 16(2):64-9. PubMed ID: 11979423
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
[TBL] [Abstract][Full Text] [Related]
12. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
Atack JR; Yu QS; Soncrant TT; Brossi A; Rapoport SI
J Pharmacol Exp Ther; 1989 Apr; 249(1):194-202. PubMed ID: 2709330
[TBL] [Abstract][Full Text] [Related]
13. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
[TBL] [Abstract][Full Text] [Related]
14. Phenserine Axonyx.
Thatte U
Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
Perissutti E; Fiorino F; Severino B; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
Pharmazie; 2007 Jun; 62(6):403-5. PubMed ID: 17663183
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A
Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292
[TBL] [Abstract][Full Text] [Related]
17. Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors.
Bolognesi ML; Andrisano V; Bartolini M; Minarini A; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 2001 Jan; 44(1):105-9. PubMed ID: 11141093
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase.
Boyle NA; Talesa V; Giovannini E; Rosi G; Norton SJ
J Med Chem; 1997 Sep; 40(19):3009-13. PubMed ID: 9301662
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
20. [The use of the multidimensional statistic analysis for investigation of anticholinesterase activity of organophosphorus inhibitors depending on their structure].
Moralev SN; Baziukin AB
Zh Evol Biokhim Fiziol; 1997; 33(3):302-7. PubMed ID: 9479389
[No Abstract] [Full Text] [Related]
[Next] [New Search]